Search clinical trials for: CMC-544 (Inotuzumab Ozogamycin)
Total 87 results
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
PfizerCompletedLymphoma, B-CellUnited States, Spain, France, Switzerland, United Kingdom, Belgium, Germany
-
PfizerUCB PharmaCompletedLymphomaUnited States, Belgium, Japan, Korea, Republic of, Germany, Hong Kong, Hungary, Netherlands, Singapore
-
Institute of Hematology & Blood Diseases HospitalNot yet recruiting
-
PfizerUCB PharmaCompletedLymphoma, B-CellUnited States, France, United Kingdom, Singapore, Korea, Republic of, Germany
-
PfizerCompletedPrecursor Cell Lymphoblastic Leukemia-LymphomaUnited Kingdom
-
PfizerUCB PharmaCompletedAcute Lymphocytic LeukemiaUnited States
-
M.D. Anderson Cancer CenterWyeth is now a wholly owned subsidiary of PfizerCompletedAcute Lymphoblastic LeukemiaUnited States
-
PfizerUCB PharmaCompletedB-Cell LymphomaUnited States, Belgium, Korea, Republic of, Switzerland, France, Poland, Spain, Hong Kong, Australia, Germany, Italy, Netherlands, United Kingdom
-
PfizerCompleted
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)TerminatedRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic Leukemia | CD22 PositiveUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingAcute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | Recurrent B Acute Lymphoblastic LeukemiaUnited States
-
PfizerUCB PharmaTerminatedLymphoma, Non-HodgkinCanada, United States, Spain, France, Singapore, Taiwan, Japan, Ireland, Belgium, United Kingdom, Germany, Slovakia, Thailand, Croatia, Czechia, Russian Federation, India, Sweden, Poland, Bulgaria, Hungary, Lithuania, Mexico, Puerto Rico and more
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedBlast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive | Blasts More Than 5 Percent of Bone Marrow Nucleated Cells | B Acute Lymphoblastic Leukemia With t(9;22)(q34... and other conditionsUnited States
-
Cristiana SessaCompletedB-cell Lymphoma RefractorySwitzerland
-
Nicola GoekbugetRecruitingPrecursor Cell Lymphoblastic LeukemiaGermany
-
Novartis PharmaceuticalsWithdrawn
-
Gruppo Italiano Malattie EMatologiche dell'AdultoRecruitingAcute Lymphoid LeukemiaItaly
-
PfizerCompletedLeukemia | Precursor b-Cell Lymphoblastic Leukemia-Lymphoma | ACUTE LYMPHOBLASTIC LEUKEMIAUnited States, Spain, Taiwan, Singapore, India, Hungary, Turkey, Poland
-
PfizerActive, not recruiting
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruitingAcute Lymphoid LeukemiaChina
-
Versailles HospitalActive, not recruitingAcute Lymphoblastic Leukemia (ALL) - Philadelphia Chromosome (Ph)-Negative CD22+ B-cell Precursor (BCP)France
-
Institute of Hematology & Blood Diseases HospitalNot yet recruitingMinimal Residual Disease | Bone Marrow Transplant | Ph+ ALLChina
-
Roswell Park Cancer InstitutePfizerWithdrawnRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | CD22 Positive | Allogeneic Hematopoietic Stem Cell Transplantation Recipient | Blasts 5 Percent or More of Peripheral Blood White Cells | Lymphoblasts... and other conditionsUnited States
-
PfizerActive, not recruitingAcute Lymphoblastic LeukemiaChina
-
PfizerUCB PharmaCompletedLymphoma, B-CellKorea, Republic of, Canada, Belgium, Singapore, United States, Hong Kong, Japan, United Kingdom, France
-
SWOG Cancer Research NetworkNational Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Acute Lymphoblastic Leukemia | B-cell Adult Acute Lymphoblastic Leukemia | Acute Leukemias of Ambiguous Lineage | Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic LeukemiaUnited States
-
PfizerRecruitingACUTE LYMPHOBLASTIC LEUKEMIAItaly, Spain, Belgium, Germany, Hungary, Switzerland, Norway, Austria, France, Czechia, Finland, Netherlands, Sweden, Israel, Poland, Denmark, Greece, Slovakia
-
AbbottBristol-Myers SquibbTerminated
-
Beijing HuiLongGuan HospitalCompleted
-
Swedish Orphan BiovitrumRecruitingHereditary Tyrosinemia, Type IChina
-
Bristol-Myers SquibbAbbVieCompletedSmoldering Multiple MyelomaUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome NegativeUnited States
-
Leland MethenyRecruitingAcute Lymphocytic LeukemiaUnited States
-
Sheng-Li Xue, MDNorthern Jiangsu Province People's Hospital; The Second People's Hospital of... and other collaboratorsRecruitingHematopoietic Stem Cell Transplantation | ALL | MRD-positiveChina
-
PfizerCompletedAdult Relapsed/Refractory B Cell Acute Lymphoblastic LeukemiaIndia
-
Institute of Hematology & Blood Diseases Hospital...Not yet recruiting
-
M.D. Anderson Cancer CenterNot yet recruitingB-cell Acute Lymphocytic Leukemia | Relapsed/RefractoryUnited States
-
PfizerUCB PharmaCompletedAcute Lymphoblastic LeukemiaUnited States, Canada, France, Spain, China, United Kingdom, Australia, Taiwan, Singapore, Korea, Republic of, Japan, Germany, Czechia, Poland, Italy, Netherlands, Argentina, Finland, Hungary, Sweden
-
M.D. Anderson Cancer CenterRecruiting
-
St. Jude Children's Research HospitalPfizerRecruitingAcute Lymphoblastic LeukemiaUnited States
-
Mats HeymanAssistance Publique - Hôpitaux de Paris; Karolinska Institutet; Pfizer; The Swedish... and other collaboratorsRecruitingLeukemia, Acute LymphoblasticBelgium, United Kingdom, Denmark, Germany, Portugal, Netherlands, Estonia, France, Finland, Iceland, Norway, Sweden, Lithuania, Ireland
-
PfizerUCB PharmaTerminatedLymphoma, FollicularBelgium, United States, Canada, Hong Kong, Korea, Republic of, Portugal, Spain, Poland, India, Argentina, Italy, Mexico, Russian Federation, South Africa
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)WithdrawnRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditions
-
Wake Forest University Health SciencesNational Cancer Institute (NCI)Approved for marketingRecurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Del(5q) | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8... and other conditionsUnited States
-
The Lymphoma Academic Research OrganisationPfizerCompletedDiffuse Large B-Cell LymphomaFrance, Belgium
-
Dana-Farber Cancer InstituteAbbVieRecruitingB-Cell Lymphoma | B-cell Acute Lymphoblastic Leukemia | ALLUnited States
-
University of VirginiaPfizer; University of Wisconsin, Madison; Vanderbilt University; Virginia Commonwealth...Active, not recruitingB-cell Acute Lymphoblastic LeukemiaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI)TerminatedAdult Acute Megakaryoblastic Leukemia (M7) | Adult Acute Minimally Differentiated Myeloid Leukemia (M0) | Adult Acute Monoblastic Leukemia (M5a) | Adult Acute Monocytic Leukemia (M5b) | Adult Acute Myeloblastic Leukemia With Maturation (M2) | Adult Acute Myeloblastic Leukemia Without Maturation... and other conditionsUnited States